#cediranib

“Women with advanced ovarian or cervical cancer are living longer, with fewer disease symptoms, and that reflects advances across clinical and supportive therapies.”

-Charlie Schmidt discusses gains in ovarian and cervical cancer treatment drugs, in particular, cediranib uses in ovarian cancer.

More information is available in a full collection on cervical cancer and HPV from JNCI: Journal of the National Cancer Institute, available until May 2017.